Jan Ohrstrom
ONWARD® Medical Announces Changes to Board of Directors, Including Addition of Medtech Leader Rob ten Hoedt as Incoming Chairman
October 21, 2024 01:30 ET | ONWARD Medical NV
ONWARD® Medical Announces Changes to Board of Directors, Including Addition of Medtech Leader Rob ten Hoedt as Incoming Chairman
ONWARD ARC-BCI®
ONWARD® Medical signe un accord avec le CEA pour obtenir les droits exclusifs de la technologie d’interface cerveau machine (BCI) WIMAGINE® de Clinatec
October 15, 2024 01:30 ET | ONWARD Medical NV
CE COMMUNIQUÉ DE PRESSE CONTIENT DES INFORMATIONS PRIVÉES AU SENS DE L'ARTICLE (7)(1) DU RÈGLEMENT EUROPÉEN SUR LES ABUS DE MARCHÉ (596/2014) L'entreprise obtient les droits exclusifs pour intégrer...
ONWARD ARC-BCI®
ONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIMAGINE® Brain-Computer Interface (BCI) Technology
October 15, 2024 01:30 ET | ONWARD Medical NV
ONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIMAGINE® Brain-Computer Interface (BCI) Technology
Principaux actionnaires
ONWARD® Medical Annonce la Cotation de ses Titres sur le Marché Euronext Paris
September 20, 2024 13:45 ET | ONWARD Medical NV
La société a des racines françaises et des liens significatifs avec la France La société collabore étroitement avec le CEA-Clinatec, institut de recherche biomédicale de renommée mondiale financé par...
ONWARD_Logotype®_Red.png
ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury
September 19, 2024 01:30 ET | ONWARD Medical NV
ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury
ONWARD_Logotype®_Red.png
ONWARD® Medical annonce le troisième implant de son système d'interface cerveau-machine (BCI) pour restaurer le mouvement après une lésion de la moelle épinière
September 19, 2024 01:30 ET | ONWARD Medical NV
ONWARD® Medical annonce le troisième implant de son système d'interface cerveau-machine pour restaurer le mouvement après une lésion de la moelle épinière
ONWARD_Logotype®_Red.png
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update
September 10, 2024 01:30 ET | ONWARD Medical NV
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update
ONWARD_Logotype®_Red.png
ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System
September 03, 2024 01:30 ET | ONWARD Medical NV
ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System
ONWARD_Logotype®_Red.png
ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update
August 27, 2024 12:53 ET | ONWARD Medical NV
ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update
ONWARD_Logotype®_Red.png
ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights
August 05, 2024 17:47 ET | ONWARD Medical NV
ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights